Open AccessFaecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases
Author(s) -
Anthony Buisson,
W Mak,
Michael J. Andersen,
Donald Lei,
Stacy A. Kahn,
Joel Pekow,
R. D. Cohen,
Nada Zmeter,
Bruno Pereira,
David T. Rubin
Publication year - 2019
Publication title -
journal of crohn's and colitis
Language(s) - English
Resource type - Journals
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1093/ecco-jcc/jjz023
Subject(s) - calprotectin , medicine , inflammatory bowel diseases , faecal calprotectin , inflammatory bowel disease , gastroenterology , de escalation , oncology , disease
To assess faecal calprotectin [Fcal] levels before and after therapeutic de-escalation, to predict clinical relapse in patients with inflammatory bowel disease [IBD].